stockportfolio.pro
Stocks / OPCH vs TLX
OPCH vs TLX
Option Care Health, Inc. and Telix Pharmaceuticals Limited side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Option Care Health, Inc. (OPCH) | Telix Pharmaceuticals Limited (TLX) | |
|---|---|---|
| Market cap | $3.4B | $3.2B |
| Revenue (latest FY) | $5.65B | $803.79M |
| Net income (latest FY) | $207.59M | $-7.13M |
| Revenue growth (5y CAGR) | 13.3% | 94.7% |
| Net margin | 3.7% | -0.9% |
| Return on equity | 15.7% | -1.7% |
| P/E ratio | 16.8 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 6 | 2 |
| Positive free cash flow | Yes | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open OPCH — free Open TLX — freeFrequently asked questions
Which is bigger, OPCH or TLX?
Option Care Health, Inc. is larger by market capitalization — $3.4B versus $3.2B.
Which grows faster, OPCH or TLX?
Over the last five fiscal years, Telix Pharmaceuticals Limited grew revenue faster — 94.7%/yr versus 13.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.